Letter Epublish
PubMed: 40486210 DOI: 10.1016/j.rpth.2025.102861
Reply to "Reevaluating thromboprophylaxis in COVID-19 outpatients: the case for a targeted, risk-based approach".
Res Pract Thromb Haemost 9(3):102861
Authors: Davide Di Vece, Jean M Connors, Stefano Barco
Affiliations
- Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.
- Department of Internal Medicine, First Clinic of Internal Medicine, University of Genoa, Genoa, Italy.
- Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
- Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
MeSH
Covid-19, Outpatients